These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 37864414)

  • 1. Survival outcomes of different neoadjuvant treatment regimens in patients with locally advanced rectal cancer and MRI-detected extramural venous invasion.
    Chen M; Ma Y; Song YW; Huang J; Gao YH; Zheng J; He F
    Cancer Med; 2023 Nov; 12(21):20523-20537. PubMed ID: 37864414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of neoadjuvant chemotherapy with or without intensity-modulated radiotherapy for patients with rectal cancer.
    He F; Yu L; Ding Y; Li ZH; Wang J; Zheng J; Chen HY; Liu S; Pang XL; Ajani JA; Wan XB
    Cancer Sci; 2020 Nov; 111(11):4205-4217. PubMed ID: 32860448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment MRI-detected extramural venous invasion as a prognostic and predictive biomarker for neoadjuvant chemoradiotherapy in non-metastatic rectal cancer: a propensity score matched analysis.
    Yang SY; Bae H; Seo N; Han K; Han YD; Cho MS; Hur H; Min BS; Kim NK; Lee KY; Lim JS
    Eur Radiol; 2024 Jun; 34(6):3686-3698. PubMed ID: 37994967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Predictive Value of Pre-/Postneoadjuvant Chemoradiotherapy MRI Characteristics for Patient Outcomes in Locally Advanced Rectal Cancer.
    Meng Y; Wan L; Zhang C; Wang C; Ye F; Li S; Zou S; Cheng J; Xu K; Zhou C; Zhang H
    Acad Radiol; 2020 Sep; 27(9):e233-e243. PubMed ID: 31780392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI morphologic and clinicopathologic characteristics for predicting outcomes in patients with locally advanced rectal cancer.
    Meng Y; Wan L; Ye F; Zhang C; Zou S; Zhao X; Xu K; Zhang H; Zhou C
    Abdom Radiol (NY); 2019 Nov; 44(11):3652-3663. PubMed ID: 30456561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
    Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306
    [No Abstract]   [Full Text] [Related]  

  • 7. MRI-defined high-risk rectal cancer patients: outcome comparison between neoadjuvant chemoradiotherapy plus TME and TME plus adjuvant chemotherapy or TME alone.
    Jia X; Xie P; Bi L; Meng X; Wang Z; Hong N; Wang Y
    Br J Radiol; 2021 Apr; 94(1120):20201221. PubMed ID: 33591799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging performed before and after preoperative chemoradiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion.
    Prampolini F; Taschini S; Pecchi A; Sani F; Spallanzani A; Gelsomino F; Kaleci S; Torricelli P
    Abdom Radiol (NY); 2020 Oct; 45(10):2941-2949. PubMed ID: 30483843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of patients with locally advanced rectal cancer eligible for neoadjuvant chemotherapy alone: Results of a retrospective study.
    Han YM; Qi WX; Wang SB; Cao WG; Chen JY; Cai G
    Cancer Med; 2023 Jun; 12(12):13309-13318. PubMed ID: 37148548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 11. MRI of Extramural Venous Invasion in Locally Advanced Rectal Cancer: Relationship to Tumor Recurrence and Overall Survival.
    Zhang XY; Wang S; Li XT; Wang YP; Shi YJ; Wang L; Wu AW; Sun YS
    Radiology; 2018 Dec; 289(3):677-685. PubMed ID: 30152742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial.
    Mei WJ; Wang XZ; Li YF; Sun YM; Yang CK; Lin JZ; Wu ZG; Zhang R; Wang W; Li Y; Zhuang YZ; Lei J; Wan XB; Ren YK; Cheng Y; Li WL; Wang ZQ; Xu DB; Mo XW; Ju HX; Ye SW; Zhao JL; Zhang H; Gao YH; Zeng ZF; Xiao WW; Zhang XP; Zhang X; Xie E; Feng YF; Tang JH; Wu XJ; Chen G; Li LR; Lu ZH; Wan DS; Bei JX; Pan ZZ; Ding PR
    Ann Surg; 2023 Apr; 277(4):557-564. PubMed ID: 36538627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial.
    Patel UB; Brown G; Machado I; Santos-Cores J; Pericay C; Ballesteros E; Salud A; Isabel-Gil M; Montagut C; Maurel J; Ramón-Ayuso J; Martin N; Estevan R; Fernandez-Martos C
    Ann Oncol; 2017 Feb; 28(2):344-353. PubMed ID: 28426108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of MRI-detected extramural vascular invasion (mrEMVI) for rectal cancer patients treated with neoadjuvant therapy: a meta-analysis.
    Chen S; Li N; Tang Y; Shi J; Zhao Y; Ma H; Wang S; Li YX; Jin J
    Eur Radiol; 2021 Dec; 31(12):8827-8837. PubMed ID: 33993333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China.
    Zhang G; Zhang C; Sun N; Xue L; Yang Z; Fang L; Zhang Z; Luo Y; Gao S; Xue Q; Mu J; Gao Y; Tan F; He J
    J Cancer Res Clin Oncol; 2022 Apr; 148(4):943-954. PubMed ID: 34013382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of state-of-the-art rectal MRI sequences for the diagnosis of extramural vascular invasion in locally advanced rectal cancer after preoperative chemoradiotherapy: dos or maybes?
    Crimì F; Angelone R; Corso A; Bao QR; Cabrelle G; Vernuccio F; Spolverato G; Pucciarelli S; Quaia E
    Eur Radiol; 2023 Oct; 33(10):6852-6860. PubMed ID: 37115215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI Assessment of Extramural Venous Invasion Before and After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer and Its Association with Disease-Free and Overall Survival.
    Thompson HM; Bates DDB; Pernicka JG; Park SJ; Nourbakhsh M; Fuqua JL; Fiasconaro M; Lavery JA; Wei IH; Pappou EP; Smith JJ; Nash GM; Weiser MR; Paty PB; Garcia-Aguilar J; Widmar M
    Ann Surg Oncol; 2023 Jul; 30(7):3957-3965. PubMed ID: 36964328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 19. MRI-predicted extramural vascular invasion and tumour deposit are main predictors of disease-free survival in patients undergoing surgical resection for rectal cancer.
    Di Fabio F; Allievi N; Lord A; Bhagwanani A; Venkatasubramaniam A; Arnold S; Moran B
    BJS Open; 2024 Jan; 8(1):. PubMed ID: 38170894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of MRI Risk Stratification System on the Survival Benefits of Adjuvant Chemotherapy After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
    Zhao R; Zhao W; Zhu Y; Wan L; Chen S; Zhao Q; Zhao X; Zhang H
    Acad Radiol; 2023 Sep; 30 Suppl 1():S164-S175. PubMed ID: 37369619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.